Immunology Notes

Immunity

  • Immunology is the study of how the body distinguishes itself from everything else.

  • All multicellular organisms have some type of recognition system.

    • Animals, such as sponge colonies.

    • Plants, such as pollen.

  • The immune system is a vertebrate development from older recognition systems.

Historical Context

  • 430 BC: Evidence of understanding immunity.

  • 1500-1802: Early observations and experiments.

  • 1805: Questioning if the chickenpox vaccine would provide protection against smallpox.

  • 2021: Coronavirus vaccine candidates developed using various methods.

    • Nucleic acid vaccines

    • Viral vector vaccines

    • Protein-based vaccines

Host Defense

  • Steps of infection:

    • Adherence

    • Multiplication

    • Evasion of host defense

    • Cause damage

  • Host defense relies on disrupting one or more of these steps.

  • No defense layer is perfect.

Components of Immune Response

  • First line of defense: Innate Immunity

    • Intact skin

    • Mucous membranes and their secretions

    • Normal microbiota

  • Second line of defense:

    • Phagocytes (neutrophils, eosinophils, dendritic cells, and macrophages)

    • Inflammation

    • Fever

    • Antimicrobial substances

  • Third line of defense: Adaptive Immunity

    • Specialized lymphocytes: T cells and B cells

    • Antibodies

Physical and Chemical Barriers to Infection

  • Physical barriers: Epithelial layers of skin and mucosal/glandular tissues.

  • Chemical barriers: Acidic pH and antimicrobial proteins and peptides.

Cellular Responses to Infection

  • Phagocytosis and degradation by macrophages and dendritic cells.

  • Cell activation

  • NK cell activation

  • Release of cytokines and chemokines, leading to inflammation.

  • Production of antimicrobial substances.

  • Pathogen elimination.

Lymphoid Tissues

  • Nasal-associated lymphoid tissue (NALT)

  • Tonsils and Adenoids

  • Bronchus-associated lymphoid tissue (BALT)

  • Skin-associated lymphoid tissue (SALT)

  • One of many lymph nodes that comprise the Axillary lymph nodes

  • Mesenteric lymph nodes

  • Gut-associated lymphoid tissue (GALT)

  • Isolated lymphoid follicles

  • Reproductive tract-associated lymphoid tissue

  • Peyer's patches

  • Inguinal lymph nodes

  • Para-aortic lymph nodes

Cells

  • Granulocytes:

    • Neutrophils

    • Eosinophils: deal w/parasitic infections

    • Basophils

    • Mast cells: release histamine

  • Monocytes

  • Macrophages: Phagocitize

  • Dendritic cells: present samples

  • Megakaryocytes: Laquire antiboties

Phagocytosis

  • Process:

    • Chemotaxis: Phagocyte is attracted to the microbe.

    • Adherence: Phagocyte attaches to microbe (PAMPs binding to TLRs).

    • Ingestion: Microbe is ingested forming a phagosome.

    • Formation of phagolysosome: Phagosome fuses with a lysosome.

    • Digestion: Microbe is digested by enzymes.

    • Discharge: Waste materials are discharged.

Inflammation

  • Symptoms:

    • Redness

    • Swelling (edema)

    • Pain

    • Heat

Steps of Inflammation

  • Tissue damage causes release of vasoactive and chemotactic factors, increasing blood flow and capillary permeability.

  • Permeable capillaries allow influx of fluid (exudate) and cells.

  • Phagocytes migrate to the site of inflammation (chemotaxis).

Inflammation Pathways

  • Prostaglandins lead to fever via the hypothalamus.

  • IL-1, TNF-α, IL-6 influence the hypothalamus and pituitary, resulting in the release of ACTH and corticosteroids from the adrenal cortex.

  • Cytokines (IL-1, TNF-α) stimulate the liver to produce acute-phase proteins (C-reactive protein, serum amyloid A, fibrinogen, mannose-binding protein, complement components).

  • IL-6 and TNF-0 act on the bone marrow, leading to leukocytosis.

Complement Cascade

  • Classical pathway: Initiated by antigen-antibody complexes.

  • Lectin pathway: Activated by microbial cell walls.

  • Alternative pathway: Triggered by microbial surfaces.

Complement Functions

  • Activation of inflammatory response

  • Lysis

  • Opsonization

  • Clearance of immune complexes

Mechanism of IFN α and IFN β

  • Virus-infected host cells produce interferon mRNA (IFN-mRNA).

  • Translation of IFN-mRNA leads to the production of alpha and beta interferons.

  • Interferons alert neighboring cells.

  • Neighboring cells transcribe antiviral protein genes.

  • Translation produces antiviral proteins (AVPs) that interfere with viral replication.

Acquired Immunity

  • Specific for a particular antigen.

  • Developed by contact with antigen.

  • Has memory: More potent on subsequent exposures.

  • Basis for vaccination.

  • Discriminates between self and non-self.

  • Based on the action of lymphocytes.

    • Humoral response (B lymphocytes)

    • Cell-mediated response (T lymphocytes)

Lymphocytes

  • B lymphocytes (B cells): involved in the humoral response

  • T lymphocytes (T cells): involved in cell-mediated response.

Generation of Diversity

  • Selection (positive selection)

    • Keep ones that bind to foreign invaders

  • Deletion

    • delete anything "that binds to me" (own body)

B Cells

  • Antigen-binding receptor: antibody

Antibodies

  • Surface antibody

  • Soluble antibody

  • Antigen-binding site

  • Disulfide bonds

  • Light chain and Heavy chain

Antibody Types

  • IgG: most common, can cross the placenta

  • IgD: ignore!

  • IgE: binds to mast cells and deals with parasites and allergies

  • IgA (dimer): secretions, respiratory, digestive mucus, breast milk, etc. -bind virus in mucus

  • IgM (pentamer): first antibody, activates complement

Antibody Protection Mechanisms

  • Virus and toxin neutralization: Prevents pathogen-host binding.

  • Opsonization: Enhances phagocytosis.

  • Complement fixation: Leads to formation of the membrane attack complex (MAC).

  • Antibody-Dependent Cell-mediated Cytotoxicity (ADCC): NK-induced apoptosis.

T Cells

  • Tc cell : Class I MHC with CD8 receptors

  • TH cell : Class II MHC with CD4 receptors

Cytotoxic T Cells

  • Delete themselves

  • Cell-mediated immunity

T Helper Cells

  • Antigen presenting cells:

    • MHC class II - exogenous, external threats

    • MHC class I - endogenous, found inside cell

T Helper Cells types

  • Naïve -> TH1: Bacteria

    • IFN-γ, IL-12

  • Naïve -> TH17: Fungi

    • IL-6, IL-23

  • Naïve -> TH2: Helminth, Allergies

    • IL-4, IL-5, IL-13

  • Naïve -> Treg: Autoimmunity

    • IL-10, TGF-β

Humoral vs. Cell-Mediated Response

  • Humoral: B lymphocytes

  • Cell-mediated: T lymphocytes (T-helper cells and Cytotoxic T-cells)

Antigen Presentation

  • Foreign proteins, viruses, bacteria, parasites, fungi.

  • Internalized antigen digested by cell

  • Altered self cell presents antigen

  • Class II MHC: TH cell

  • Class I MHC: Tc cell

  • Activated T cell secretes cytokines that contribute to the activation of B cells, Tc cells, and other cells.

Vaccines

  • Pasteur's Rabies Vaccine

Vaccine Statistics

Disease

Prevaccine

Postvaccine

Reduction (%)

Smallpox

48,164

0

100

Diphtheria

175,885

0

100

Measles

503,282

79

99.98

Mumps

152,209

145

98.90

Pertussis ("whooping cough")

147,271

964

99.35

Paralytic polio

16,316

0

100

Rubella (German measles)

47,745

0

100

Tetanus ("lockjaw")

1,314

1

99.92

Invasive H. influenzae

20,000

356

98.22

Vaccine Development

  • Clinical trials:

    • Phase I: 20-80 participants

    • Phase II: 100-300 participants

    • Phase III: 1000--3000 participants

    • Phase IV: 1000+ participants: To confirm safety and effectiveness

Immunologic Memory

  • The immunological memory lasts about 12 months

Herd Immunity

  • Herd immunity occurs when a large portion of the community (the herd) becomes immune to a disease, making spread from person to person unlikely.

R0 of Contagious Diseases

Infectious Agent

Disease

R0

Infectious Period (days)

Mode of Transmission

HIT (%)

Measles virus

Measles

12-18

6-7

aerosol

92-94

Varicella-zoster

Chickenpox

10-11

12-14

aerosol

90-92

SARS-CoV-2 (ō)

COVID-19

5-8

10

droplet and aerosol

80-89

Poliovirus

Poliomyelitis

5

14-20

fecal-oral

80-86

Variola virus

Smallpox

3.7-7

2-3

droplets

71-83

B. Pertussis

Pertussis

12-18

7-10

droplets

82

SARS-CoV-2 (wt)

COVID-19

2.4-3.4

10

droplet and aerosol

58-70

Ebola virus

EVD

1.8

7-14

body fluids

44

MERS-CoV

MERS

0.47

n/a

droplets

<1

Monitoring Vaccine Safety

  • Active surveillance: DoD VAECS, NHSN, VSD, PRISM, BEST Initiative

  • Passive surveillance: VAERS

  • Case consults: CISA Project

Vaccine Efficacy

  • Greater risk of disease, hospitalization, and death among unvaccinated vs. vaccinated people.

    • 8-fold reduction in disease incidence

    • 25-fold reduction in hospitalization incidence

    • 25-fold reduction in death incidence